International Affairs: Ensuring Drug Quality in Global Health Programs

Home > Diane Publishing Books >

Our Price: $20.00

By David Gootnick (au); Marcia Crosse (au)
Year: 2012
Pages: 29
Binding Paperback
ISBN 978-1-4578-3726-5

Product Code: 1457837269

Description

The U.S. supports global health programs primarily through the U.S. Agency for International Development (USAID) and the Centers for Disease Control and Prevention (CDC) and by providing contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). USAID and CDC implement the President's Emergency Plan for AIDS Relief (PEPFAR), which provides antiretroviral treatment to more than 3.9 million people, and the President's Malaria Initiative (PMI), which has procured and distributed over 67 million malaria treatments. In addition, the Global Fund provides antiretroviral drugs to about 3.3 million people, has supported tuberculosis treatment for 8.6 million, and enabled treatment of 170 million malaria cases. Concerns have been raised about the potential for substandard drugs to enter the supply chains of global health programs. Substandard drugs, which may be caused by poor manufacturing practices, improper storage or distribution, or tampering, can have serious public health consequences, including ineffective treatment of diseases, adverse reactions in patients, and drug resistant strains of pathogens. This report reviewed safeguards in place to ensure drug products procured with U.S. foreign aid funds are of assured quality. It examined (1) the regulatory and policy requirements intended to ensure the quality of drugs procured with U.S. aid funds; and (2) the systems in place to monitor drug quality in supply chains used by programs receiving U.S. foreign aid funds. Figures. This is a print on demand report.

Share your knowledge of this product with other customers... Be the first to write a review